International Journal of Drug Policy

International Journal of Drug Policy is a monthly peer-reviewed journal published by Elsevier, covering drug policy and addiction medicine. Founded in 1987, it provides a forum for the dissemination of current research, reviews, debate, and critical analysis on drug use and drug policy in a global context, with a 2025 impact factor of 4.4, indexed in SSCI.《国际药物政策杂志》（International Journal of Drug Policy, 简称 IJDP）是由 Elsevier 出版的月刊同行评审期刊，涵盖药物政策与成瘾医学。该刊创刊于 1987 年，为全球背景下药物使用与药物政策研究、综述、辩论与批判性分析的传播提供论坛，2025 年影响因子为 4.4，被 SSCI 收录。

Scope

The journal's stated aim is to provide a forum for the dissemination of current research, reviews, debate, and critical analysis on drug use and drug policy in a global context, with its official scope covering:刊物官方宗旨为提供全球背景下药物使用与药物政策研究、综述、辩论与批判性分析传播的论坛，官方声明的征稿范围包括：

• Drug policy analysis: original research on national and international drug policies, including prohibition, legalization, regulation, and harm reduction approaches.药物政策分析： 关于国家与国际药物政策的原创研究，包括禁止、合法化、监管与减害方法。
• Addiction and substance use: studies on substance use disorders, addiction mechanisms, patterns of drug use, and the social determinants of drug-related harm.成瘾与物质使用： 关于物质使用障碍、成瘾机制、药物使用模式以及药物相关危害社会决定因素的研究。
• Public health and epidemiology: research on the epidemiology of drug use, drug-related harms, overdose prevention, and public health responses to substance use.公共卫生与流行病学： 关于药物使用流行病学、药物相关危害、过量预防以及物质使用公共卫生应对的研究。
• Treatment and intervention: studies on treatment, recovery, and interventions for substance use disorders, including pharmacotherapy and psychosocial approaches.治疗与干预： 关于物质使用障碍治疗、康复与干预的研究，包括药物治疗与心理社会方法。
• Article types: the journal publishes original research articles, review articles, policy analyses, commentaries, and debates on drug use and drug policy.栏目设置： 该刊发表关于药物使用与药物政策的原创研究论文、综述、政策分析、评论与辩论。

History

• Founding: the journal was established in 1987, originally titled the Mersey Drugs Journal, and was later renamed to reflect its international scope.创刊： 该刊于 1987 年创刊，原名为《默西药物杂志》，后更名为现名以反映其国际范围。
• Elsevier publication: IJDP is published by Elsevier, ensuring high editorial standards and broad international distribution.Elsevier 出版： IJDP 由 Elsevier 出版，确保高编辑标准与广泛的国际传播。
• Global focus: throughout its history, the journal has emphasized a global perspective on drug policy, representing a wide range of material from around the world.全球聚焦： 在其发展历程中，该刊始终强调药物政策的全球视角，刊载来自世界各地的广泛内容。
• Publication frequency: the journal publishes monthly, ensuring timely dissemination of important research and debate on drug policy.出版频率： 该刊每月出版，确保药物政策重要研究与辩论的及时传播。

Editors

The journal is led by an editor-in-chief supported by an editorial board:该刊由主编领导，编委会协助工作：

• Editor-in-chief: Alison Ritter, PhD of the University of New South Wales, Sydney, Australia, serves as the editor-in-chief.主编： 澳大利亚悉尼新南威尔士大学的艾莉森·里特（Alison Ritter, PhD）担任主编。
• Editorial leadership: the editor-in-chief is supported by editorial board members with expertise across major areas of drug policy and addiction research.编辑领导： 主编由具有药物政策与成瘾研究主要领域专长的编委会成员协助。
• Editorial board: the journal has an international editorial board comprising drug policy researchers and practitioners from leading institutions worldwide.编委会： 该刊拥有国际编委会，成员为来自全球顶尖机构的药物政策研究者与实践者。
• Open access option: authors can choose to publish open access in this journal, making their articles freely available to readers upon publication in exchange for an article processing charge.开放获取选项： 作者可选择在该刊发表开放获取文章，使论文发表后即向读者免费开放，并支付文章处理费。